[1]
A. P. R. ADITAMA, B. MA’ARIF, and F. A. MUSLIKH, “EFFECT OF OSTERIX AND OSTEOCALCIN ENHANCEMENT BY QUERCETIN (3,3′,4′,5,7-PENTAHYDROXYFLAVONE) ON OSTEOBLAST HFOB 1.19 CELL LINE”, Int J App Pharm, vol. 14, no. 1, pp. 32–35, Feb. 2022.